News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,040 Results
Type
Article (39947)
Company Profile (248)
Press Release (663845)
Multimedia
Podcasts (56)
Webinars (14)
Section
Business (204258)
Career Advice (2011)
Deals (35447)
Drug Delivery (95)
Drug Development (81117)
Employer Resources (172)
FDA (16235)
Job Trends (14882)
News (345435)
Policy (32591)
Tag
Academia (2556)
Accelerated approval (7)
Adcomms (22)
Allergies (95)
Alliances (49568)
ALS (104)
Alzheimer's disease (1423)
Antibody-drug conjugate (ADC) (150)
Approvals (16228)
Artificial intelligence (300)
Autoimmune disease (26)
Automation (18)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (113)
Biotechnology (175)
Bladder cancer (89)
Brain cancer (32)
Breast cancer (355)
Cancer (2774)
Cardiovascular disease (206)
Career advice (1681)
Career pathing (30)
CAR-T (178)
CDC (30)
Cell therapy (483)
Cervical cancer (22)
Clinical research (66706)
Collaboration (982)
Company closure (3)
Compensation (640)
Complete response letters (19)
COVID-19 (2618)
CRISPR (54)
C-suite (300)
Cystic fibrosis (109)
Data (2861)
Decentralized trials (2)
Denatured (20)
Depression (53)
Diabetes (341)
Diagnostics (6417)
Digital health (23)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (133)
Drug pricing (119)
Drug shortages (27)
Duchenne muscular dystrophy (122)
Earnings (87389)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113650)
Executive appointments (840)
FDA (17807)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (901)
Gene editing (126)
Generative AI (21)
Gene therapy (362)
GLP-1 (770)
Government (4489)
Grass and pollen (4)
Guidances (180)
Healthcare (18837)
Huntington's disease (30)
IgA nephropathy (37)
Immunology and inflammation (137)
Immuno-oncology (7)
Indications (39)
Infectious disease (2778)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (58)
Intellectual property (114)
Interviews (312)
IPO (16588)
IRA (44)
Job creations (3635)
Job search strategy (1424)
Kidney cancer (13)
Labor market (51)
Layoffs (486)
Leadership (18)
Legal (7924)
Liver cancer (78)
Lung cancer (390)
Lymphoma (200)
Machine learning (9)
Management (58)
Manufacturing (364)
MASH (86)
Medical device (13438)
Medtech (13443)
Mergers & acquisitions (19552)
Metabolic disorders (827)
Multiple sclerosis (96)
NASH (16)
Neurodegenerative disease (110)
Neuropsychiatric disorders (31)
Neuroscience (2074)
NextGen: Class of 2025 (6516)
Non-profit (4487)
Now hiring (47)
Obesity (418)
Opinion (216)
Ovarian cancer (98)
Pain (101)
Pancreatic cancer (117)
Parkinson's disease (184)
Partnered (22)
Patents (287)
Patient recruitment (148)
Peanut (50)
People (57628)
Pharmaceutical (63)
Pharmacy benefit managers (20)
Phase I (20788)
Phase II (29383)
Phase III (21867)
Pipeline (1570)
Policy (192)
Postmarket research (2563)
Preclinical (8850)
Press Release (64)
Prostate cancer (135)
Psychedelics (33)
Radiopharmaceuticals (252)
Rare diseases (442)
Real estate (5915)
Recruiting (66)
Regulatory (22534)
Reports (50)
Research institute (2324)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (47)
Schizophrenia (80)
Series A (149)
Series B (100)
Service/supplier (11)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3584)
State (2)
Stomach cancer (13)
Supply chain (73)
Tariffs (56)
The Weekly (34)
Vaccines (758)
Venture capital (50)
Weight loss (253)
Women's health (43)
Worklife (16)
Date
Last 7 days (613)
Last 30 days (2207)
Last 365 days (31183)
2025 (15931)
2024 (35219)
2023 (40076)
2022 (51174)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37554)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (719)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38158)
Australia (6227)
California (7267)
Canada (2289)
China (655)
Colorado (311)
Connecticut (312)
Delaware (188)
Europe (81994)
Florida (1092)
Georgia (244)
Hawaii (1)
Idaho (59)
Illinois (626)
India (26)
Indiana (357)
Iowa (16)
Japan (218)
Kansas (108)
Kentucky (28)
Louisiana (14)
Maine (64)
Maryland (1006)
Massachusetts (5396)
Michigan (244)
Minnesota (442)
Mississippi (3)
Missouri (87)
Montana (28)
Nebraska (25)
Nevada (79)
New Hampshire (66)
New Jersey (2026)
New Mexico (28)
New York (2048)
North Carolina (1060)
North Dakota (8)
Northern California (3195)
Ohio (229)
Oklahoma (16)
Oregon (34)
Pennsylvania (1581)
Puerto Rico (17)
Rhode Island (36)
South America (1098)
South Carolina (33)
South Dakota (1)
Southern California (2699)
Tennessee (124)
Texas (1089)
United States (26981)
Utah (216)
Virginia (181)
Washington D.C. (72)
Washington State (619)
West Virginia (4)
Wisconsin (63)
704,040 Results for "verastem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verastem Oncology to Present at the Jefferies Global Healthcare Conference
May 28, 2025
·
1 min read
Press Releases
Verastem Oncology to Present at Upcoming Investor Conferences
May 1, 2025
·
1 min read
Press Releases
Verastem Oncology Announces $75 million Private Placement
April 28, 2025
·
4 min read
Press Releases
Verastem Oncology Reports First Quarter 2025 Financial Results and Highlights Recent Business Updates
May 13, 2025
·
20 min read
Press Releases
Verastem Oncology Announces First Patient Dosed with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a U.S. Phase 1/2a Trial in KRAS G12D Advanced Solid Tumors
June 25, 2025
·
7 min read
Press Releases
Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment
May 20, 2025
·
6 min read
Press Releases
Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1 Study in China of GFH375 (VS-7375), an Oral KRAS G12D (ON/OFF) Inhibitor
June 2, 2025
·
7 min read
Press Releases
Verastem Oncology Announces Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in Frontline Metastatic Pancreatic Ductal Adenocarcinoma
May 23, 2025
·
11 min read
Press Releases
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 7, 2025
April 8, 2025
·
1 min read
Press Releases
Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025
March 25, 2025
·
11 min read
1 of 70,404
Next
